MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.922
EU - Europa 1.781
AS - Asia 1.340
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 46
OC - Oceania 6
Totale 5.355
Nazione #
US - Stati Uniti d'America 1.869
RU - Federazione Russa 736
SG - Singapore 492
CN - Cina 385
GB - Regno Unito 294
IT - Italia 216
HK - Hong Kong 134
BR - Brasile 130
SE - Svezia 127
VN - Vietnam 126
DE - Germania 95
IE - Irlanda 76
FR - Francia 70
FI - Finlandia 64
KR - Corea 48
BD - Bangladesh 34
IN - India 32
UA - Ucraina 29
CA - Canada 22
MX - Messico 20
ES - Italia 15
JP - Giappone 14
EC - Ecuador 13
TR - Turchia 11
AR - Argentina 10
NL - Olanda 10
BE - Belgio 9
ID - Indonesia 9
LT - Lituania 8
PL - Polonia 8
ZA - Sudafrica 8
NG - Nigeria 7
VE - Venezuela 7
AU - Australia 6
BJ - Benin 6
CO - Colombia 6
PH - Filippine 6
UZ - Uzbekistan 6
TG - Togo 5
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
AZ - Azerbaigian 3
CH - Svizzera 3
CL - Cile 3
IQ - Iraq 3
NO - Norvegia 3
PK - Pakistan 3
SA - Arabia Saudita 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GN - Guinea 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
MA - Marocco 2
NP - Nepal 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
BH - Bahrain 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NE - Niger 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.272
Città #
Moscow 267
Southend 248
Singapore 240
Ashburn 221
Chandler 210
San Jose 182
Dallas 168
Hong Kong 133
Jacksonville 96
Woodbridge 94
Council Bluffs 86
Verona 77
Dublin 75
Beijing 68
Ann Arbor 59
Ho Chi Minh City 47
The Dalles 45
Los Angeles 44
New York 38
Houston 31
Jinan 28
Lawrence 28
Princeton 28
Helsinki 26
Santa Clara 23
Nanjing 22
Columbus 20
Munich 20
Hanoi 18
Redmond 17
São Paulo 17
Seoul 16
Wilmington 15
Bologna 14
Buffalo 14
Shenyang 14
Sindelfingen 14
Tokyo 14
Rome 13
Frankfurt am Main 12
Redondo Beach 12
Tianjin 12
Turku 12
Hebei 11
London 11
Mexico City 9
Milan 9
Boardman 8
Brussels 8
Denver 8
Dong Ket 8
Jiaxing 8
Naples 8
Ningbo 8
Norwalk 8
Stockholm 8
Zhengzhou 8
Abuja 7
Brooklyn 7
Phoenix 7
Cotonou 6
Fuzhou 6
Hangzhou 6
Johannesburg 6
Madrid 6
Manchester 6
Montreal 6
Nanchang 6
Taiyuan 6
Tashkent 6
Warsaw 6
Wuhan 6
Changsha 5
Chennai 5
Lancaster 5
Lomé 5
Orem 5
Saint Louis 5
Seattle 5
Taizhou 5
Amman 4
Atlanta 4
Boston 4
Buttapietra 4
Cagliari 4
Da Nang 4
Dongguan 4
Guayaquil 4
Haikou 4
Hải Dương 4
Kingston 4
Kyiv 4
Lanzhou 4
Las Vegas 4
Shanghai 4
Sydney 4
Trento 4
Amsterdam 3
Betim 3
Campinas 3
Totale 3.168
Nome #
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 236
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 227
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 218
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 217
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 198
PD-L1 expression in lung non small cell carcinoma: evaluation of heterogeneity and definition of bioptic criteria for improving patients selection 182
Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors 182
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 181
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 177
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 177
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 177
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 175
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 174
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 167
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 166
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 164
Artificial intelligence in head and neck cancer diagnosis 164
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 157
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 153
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 149
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 144
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 139
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 137
Delphi expert consensus for whole slide imaging in thyroid cytopathology 131
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 128
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 124
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 123
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 118
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 112
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 105
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 104
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 91
Natural Language Processing to extract SNOMED-CT codes from pathological reports 87
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 81
AIDA: AI-Driven Intelligent Diagnostics and Analytics 51
The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolution 13
Giant atherosclerotic left main coronary artery aneurysm: from revascularization to heart transplantation 9
Correction: HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes 9
HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes 8
Totale 5.355
Categoria #
all - tutte 18.706
article - articoli 16.292
book - libri 0
conference - conferenze 1.941
curatela - curatele 0
other - altro 473
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022206 0 51 3 44 8 8 8 12 7 5 15 45
2022/2023520 30 53 44 93 41 135 16 26 60 6 16 0
2023/2024264 6 15 34 36 26 50 7 18 7 22 37 6
2024/2025781 30 41 40 131 54 55 33 21 108 44 75 149
2025/20262.492 155 126 161 431 614 157 202 142 206 165 74 59
2026/2027152 54 98 0 0 0 0 0 0 0 0 0 0
Totale 5.355